The multiple myeloma drug market

The multiple myeloma drug market

nature.com - Paul Wilcock & Rachel Webster

Multiple myeloma, the second most common haematological malignancy after non-Hodgkin lymphoma, is characterized by the abnormal proliferation of …

View on nature.com